Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.
Morales EA, Dietze KA, Baker JM, Wang A, Avila SV, Iglesias F, Radhakrishnan SV, Mause EV, Olson ML, Sun W, Rosati E, Chidester SL, Iraguha T, Fan X, Atanackovic D, Luetkens T. Morales EA, et al. Among authors: luetkens t. bioRxiv [Preprint]. 2024 Feb 11:2024.02.08.579002. doi: 10.1101/2024.02.08.579002. bioRxiv. 2024. PMID: 38370665 Free PMC article. Preprint.
Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.
Atanackovic D, Radhakrishnan SV, Bhardwaj N, Luetkens T. Atanackovic D, et al. Among authors: luetkens t. Br J Haematol. 2016 Mar;172(5):685-98. doi: 10.1111/bjh.13889. Epub 2016 Jan 20. Br J Haematol. 2016. PMID: 26791002 Free article. Review.
Immunotherapies targeting CD38 in Multiple Myeloma.
Atanackovic D, Steinbach M, Radhakrishnan SV, Luetkens T. Atanackovic D, et al. Among authors: luetkens t. Oncoimmunology. 2016 Aug 5;5(11):e1217374. doi: 10.1080/2162402X.2016.1217374. eCollection 2016. Oncoimmunology. 2016. PMID: 27999737 Free PMC article. Review.
Elotuzumab as a novel anti-myeloma immunotherapy.
Radhakrishnan SV, Bhardwaj N, Steinbach M, Weidner J, Luetkens T, Atanackovic D. Radhakrishnan SV, et al. Among authors: luetkens t. Hum Vaccin Immunother. 2017 Aug 3;13(8):1751-1757. doi: 10.1080/21645515.2017.1327487. Epub 2017 Jun 12. Hum Vaccin Immunother. 2017. PMID: 28604269 Free PMC article. Review.
Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.
Radhakrishnan SV, Bhardwaj N, Luetkens T, Atanackovic D. Radhakrishnan SV, et al. Among authors: luetkens t. Oncoimmunology. 2017 Mar 28;6(5):e1308618. doi: 10.1080/2162402X.2017.1308618. eCollection 2017. Oncoimmunology. 2017. PMID: 28638731 Free PMC article. Review.
Biomarkers for checkpoint inhibition in hematologic malignancies.
Atanackovic D, Luetkens T. Atanackovic D, et al. Among authors: luetkens t. Semin Cancer Biol. 2018 Oct;52(Pt 2):198-206. doi: 10.1016/j.semcancer.2018.05.005. Epub 2018 Jun 18. Semin Cancer Biol. 2018. PMID: 29775689 Review.
The role of surface molecule CD229 in Multiple Myeloma.
Olson M, Radhakrishnan SV, Luetkens T, Atanackovic D. Olson M, et al. Among authors: luetkens t. Clin Immunol. 2019 Jul;204:69-73. doi: 10.1016/j.clim.2018.10.006. Epub 2018 Oct 13. Clin Immunol. 2019. PMID: 30326256 Review.
57 results